HALO logo
halo search icon
AFT Pharmaceuticals Ltd.

AU$3.05

Price Change Indicator
0.19 (6.64%)
AFT Pharmaceuticals Ltd.
AFP · ASX

AFT Pharmaceuticals Ltd.

Start Trading AFP for Free

AU$3.05

Price Arrow0.19 (6.64%)
21/05/2026 01:02:48 PM
All-CompaniesAll-ConsensusGROWTH AUSHALO Ords
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AFT Pharmaceuticals Ltd. Overview

AFP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Weak

HALO Model

Mqv

Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Weak

Dividends

Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Neutral

About AFP

icon

Website

AFT Pharmaceuticals Ltd.

icon

Telephone

64.800.423.823

icon

Address

Level 1, 129 Hurstmere Road, Takapuna, Nielsen House, Auckland 0622

Description

AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World. The Australia segment caters to the Australian market. The New Zealand segment focuses on the head office function, supplier relationships and procurement of stock, and regulatory, marketing, and finance activities of the group. The Asia segment relates in the sales activities in Brunei, Hong Kong, Malaysia, Philippines, Singapore, and Vietnam markets. The Rest of the World segment consists of out licensing of internet protocol developments to markets in which the firm does not have a presence and the export of products to export markets. The company was founded by Hartley Atkinson and Marree Atkinson on September 4, 1997 and is headquartered in Auckland, New Zealand.

AFP Price Chart

Key Stats

Market Cap

AU$297.35M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

18-Jun-25

Market Data

52 weeks range

Low 2.2 - 3.37

Trade Value (12mth)

AU$988.00

1 week

4.76%

1 month

-9.21%

YTD

-4.35%

1 year

12.16%

All time high

5.25

Key Fundamentals

EPS 3 yr Growth

9.30%

EBITDA Margin

9.80%

Operating Cashflow

$11m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

105m

HALO Sector

Healthcare

Next Company Report Date

21-May-26

Next Ex Dividend Date

18-Jun-25

Next Dividend Pay Date

04-Jul-25

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AFP Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
21 May 26
21 May 26
21 May 26

AFP Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock0.140.10.1locklocklock
EPS (Fully Diluted)
 $locklocklocklock0.140.1N/Alocklocklock
Growth
 %locklocklocklock49-24.8-2.5locklocklock
PE
 Xlocklocklocklock20.823.6N/Alocklocklock
EV/EBITDA
 Xlocklocklocklock13.415.3N/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

18-Jun-25

DIV Yield

N/A

Franking Level

0%

DPSg

1.4%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

HALO Consensus Score

PEG Ratio

Consensus EPS Revisions

Short Selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

0

7 Day Change

0.00%

1 Month Change

0.00%

3 Months Change

0.00%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AFP Shortsell

Related Companies

CSL - ASX
CSL Limited

CSL · ASX

CSL Limited

AU$99.14

Price Change Indicator

0.67 (0.675%)

RMD - ASX
ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

RMD · ASX

ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

AU$29.64

Price Change Indicator

0.38 (1.30%)

SIG - ASX
Sigma Healthcare Ltd

SIG · ASX

Sigma Healthcare Ltd

AU$2.86

Price Change Indicator

0.02 (0.704%)

Want to learn more?Frequently asked questions.
What is the current share price of AFT Pharmaceuticals Ltd. (AFP:ASX)?
Halo FAQ
The current share price of AFT Pharmaceuticals Ltd. (AFP:ASX) is AUD$3.05.
What is the 52-week high share price for AFT Pharmaceuticals Ltd. (AFP:ASX)?
Halo FAQ
The 52-week high share price for AFT Pharmaceuticals Ltd. (AFP:ASX) is AUD$3.37.
What is the 52-week low share price for AFT Pharmaceuticals Ltd. (AFP:ASX)?
Halo FAQ
The 52-week low share price for AFT Pharmaceuticals Ltd. (AFP:ASX) is AUD$2.20.
What is the dividend yield for AFT Pharmaceuticals Ltd. (AFP:ASX)?
Halo FAQ
AFT Pharmaceuticals Ltd. (AFP:ASX) does not pay a dividend.
What was AFT Pharmaceuticals Ltd. (AFP:ASX) last dividend payment?
Halo FAQ
The last dividend payment of AFT Pharmaceuticals Ltd. (AFP:ASX) is AUD$0.02.
What is the franking level for AFT Pharmaceuticals Ltd. (AFP:ASX)?
Halo FAQ
AFT Pharmaceuticals Ltd. (AFP:ASX) has a franking level of 0.00%.
In which sector is AFT Pharmaceuticals Ltd. (AFP:ASX) classified?
Halo FAQ
AFT Pharmaceuticals Ltd. (AFP:ASX) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial